Echolight

Echolight is a med-tech company based in Italy that focuses on radiation-free ultrasound technology for assessing bone health. The company specializes in measuring bone mineral density (BMD) and quality, particularly at key sites like the lumbar vertebrae and proximal femur. Founded as a spin-off of the Italian National Research Council, Echolight has developed the patented REMS (Radiofrequency Echographic Multi Spectrometry) technology, which offers a safe and non-invasive alternative to traditional X-ray tests. The flagship product, EchoS, is an FDA-cleared, portable bone densitometer that allows for quick, radiation-free assessments through ultrasound scans. It is suitable for various clinical settings, including hospitals and primary care, and can even be used at patients' homes. The device calculates a unique Fragility Score, providing insights into bone microarchitecture quality and fracture risk. Echolight is committed to quality and regulatory compliance, holding multiple international certifications and maintaining a global sales network with over 40 distributors.

• Employees 53
• Founded 2010
• Total Funding $4532531